Drug Improved Metastatic Bladder Cancer Survival - Renal and Urology News

Links shared publicly online about this topic.

  • 1,152
    total visits

Drug Improved Metastatic Bladder Cancer Survival - Renal and Urology News

renalandurologynews.com

In a recent study, zoledronic acid decreased the incidence of skeletal-related events (SREs) and improved one-year survival in patients with bone metastases from bladder cancer, according to a study.

View full resource at renalandurologynews.com

Tags: Cancer, Bladder Cancer, Kidney Health, Urinary System, Drug, Urology, News

  • Share

Most Recently Shared on May 28, 2010 at 9:57 pm By:

Also Shared By:

Renal Urology News Renal Urology News

Advertisement